Heather H. Cheng

Trials

Studies that name Heather H. Cheng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:28 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT05806515 · Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  SWOG Cancer Research Network · recruiting · Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8
• N/A
  NCT04472338 · Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

  University of Washington · recruiting · Prostate Carcinoma · principal investigator
• N/A
  NCT04254133 · Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

  Fred Hutchinson Cancer Center · enrolling by invitation · Prostate Carcinoma
• N/A
  NCT03503097 · Genetic Testing for Men With Metastatic Prostate Cancer

  University of Washington · terminated · Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8 · principal investigator
• Ph2
  NCT03442556 · Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

  University of Washington · terminated · ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation · principal investigator
• Ph2
  NCT02598895 · Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

  University of Washington · completed · Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 22:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality
  P50CA097186 · NCI · FRED HUTCHINSON CANCER CENTER · fiscal years 2020 to 2026 · $490,292 awarded in 2026
  Grant number is on one of their registry trials

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• SWOG Network Group Operations Center of the NCTN
  U10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · fiscal years 2019 to 2026
  Named on NCT05806515
• Cancer Center Administration
  P30CA015704 · NCI · FRED HUTCHINSON CANCER CENTER · PI WENDY LAW · fiscal years 2018 to 2026
  Named on NCT02598895